TokenPost·
COSCIENS Biopharma Posts $2.5 Million in Q3 Revenue and $3.45 GAAP Loss Per Share
Revenue rose 66.7% from a year earlier.
More news
- TokenPost1,000 ETH Sale Leaves Wallet With 10,000 ETH
- UnchainedArca’s Jeff Dorman Calls Vitalik Buterin’s ETH Store-of-Value Pitch ‘Really Misguided’
- The DefiantBitcoin Drops Below $67,000 as Crypto Selloff Deepens
- TokenPostYuri Says 新币担保 Founder Returned to Illegal Crypto Guarantee Market
- TokenPostBitcoin Drops 4.47% in 24 Hours to $67,220 at 9:33 p.m. ET Friday
- TokenPostEther Breaks Above $1,900, Reaching $1,908 on Binance Spot